Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2009

Open Access 01-12-2009 | Original investigation

Biliary pancreatic diversion and laparoscopic adjustable gastric banding in morbid obesity: their long-term effects on metabolic syndrome and on cardiovascular parameters

Authors: Antonio E Pontiroli, Marco Laneri, Annamaria Veronelli, Francesca Frigè, Giancarlo Micheletto, Franco Folli, Gianfranco Adami, Nicola Scopinaro

Published in: Cardiovascular Diabetology | Issue 1/2009

Login to get access

Abstract

Background

Bariatric surgery is able to improve glucose and lipid metabolism, and cardiovascular function in morbid obesity. Aim of this study was to compare the long-term effects of malabsorptive (biliary pancreatic diversion, BPD), and restrictive (laparoscopic gastric banding, LAGB) procedures on metabolic and cardiovascular parameters, as well as on metabolic syndrome in morbidly obese patients.

Methods

170 patients studied between 1989 and 2001 were called back after a mean period of 65 months. 138 patients undergoing BPD (n = 23) or LAGB (n = 78), and control patients (refusing surgery and treated with diet, n = 37) were analysed for body mass index (BMI), blood glucose, cholesterol, and triglycerides, blood pressure, heart rate, and ECG indexes (QTc, Cornell voltage-duration product, and rate-pressure-product).

Results

After a mean 65 months period, surgery was more effective than diet on all items under evaluation; diabetes, hypertension, and metabolic syndrome disappeared more in surgery than in control patients, and new cases appeared only in controls. BPD was more effective than LAGB on BMI, on almost all cardiovascular parameters, and on cholesterol, not on triglyceride and blood glucose. Disappearance of diabetes, hypertension, and metabolic syndrome was similar with BPD and with LAGB, and no new cases were observed.

Conclusion

These data indicate that BPD, likely due to a greater BMI decrease, is more effective than LAGB in improving cardiovascular parameters, and similar to LAGB on metabolic parameters, in obese patients. The greater effect on cholesterol levels is probably due to the different mechanism of action.
Appendix
Available only for authorised users
Literature
1.
go back to reference Cottam DR, Mattar SG, Barinas-Mitchell E, Eid G, Kuller L, Kelley DE, Schauer PR: The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss. Obes Surg. 2004, 14: 589-600. 10.1381/096089204323093345.CrossRefPubMed Cottam DR, Mattar SG, Barinas-Mitchell E, Eid G, Kuller L, Kelley DE, Schauer PR: The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss. Obes Surg. 2004, 14: 589-600. 10.1381/096089204323093345.CrossRefPubMed
2.
go back to reference McGill HC, McMahan CA, Herderick EE, Zieske AW, Malcom GT, Tracy RE, Strong JP: Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Obesity accelerates the progression of coronary atherosclerosis in young men. Circulation. 2002, 105: 2712-2718. 10.1161/01.CIR.0000018121.67607.CE.CrossRefPubMed McGill HC, McMahan CA, Herderick EE, Zieske AW, Malcom GT, Tracy RE, Strong JP: Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Obesity accelerates the progression of coronary atherosclerosis in young men. Circulation. 2002, 105: 2712-2718. 10.1161/01.CIR.0000018121.67607.CE.CrossRefPubMed
3.
go back to reference Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, Kannel WB, Vasan RS: Obesity and the risk of heart failure. N Engl J Med. 2002, 347: 305-313. 10.1056/NEJMoa020245.CrossRefPubMed Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, Kannel WB, Vasan RS: Obesity and the risk of heart failure. N Engl J Med. 2002, 347: 305-313. 10.1056/NEJMoa020245.CrossRefPubMed
4.
go back to reference Laakso M, Edelman SV, Brechtel G: Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man: a novel mechanism for insulin resistance. J Clin Invest. 1990, 85: 1844-1852. 10.1172/JCI114644.PubMedCentralCrossRefPubMed Laakso M, Edelman SV, Brechtel G: Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man: a novel mechanism for insulin resistance. J Clin Invest. 1990, 85: 1844-1852. 10.1172/JCI114644.PubMedCentralCrossRefPubMed
5.
go back to reference Festa A, D'Agostino R, Howard G, Mykkänen L, Tracy RP, Haffner SM: Chronic Subclinical Inflammation as Part of the Insulin Resistance Syndrome: The Insulin Resistance Atherosclerosis Study (IRAS). Circulation. 2000, 102: 42-47.CrossRefPubMed Festa A, D'Agostino R, Howard G, Mykkänen L, Tracy RP, Haffner SM: Chronic Subclinical Inflammation as Part of the Insulin Resistance Syndrome: The Insulin Resistance Atherosclerosis Study (IRAS). Circulation. 2000, 102: 42-47.CrossRefPubMed
6.
go back to reference Alvarez GE, Beske SD, Ballard TP, Davy KP: Sympathetic neural activation in visceral obesity. Circulation. 2002, 106: 2533-2536. 10.1161/01.CIR.0000041244.79165.25.CrossRefPubMed Alvarez GE, Beske SD, Ballard TP, Davy KP: Sympathetic neural activation in visceral obesity. Circulation. 2002, 106: 2533-2536. 10.1161/01.CIR.0000041244.79165.25.CrossRefPubMed
7.
go back to reference Ziccardi P, Nappo F, Giugliano G, Esposito K, Marfella R, Cioffi M, D'Andrea F, Molinari AM, Giugliano D: Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation. 2002, 105: 804-809. 10.1161/hc0702.104279.CrossRefPubMed Ziccardi P, Nappo F, Giugliano G, Esposito K, Marfella R, Cioffi M, D'Andrea F, Molinari AM, Giugliano D: Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation. 2002, 105: 804-809. 10.1161/hc0702.104279.CrossRefPubMed
8.
go back to reference Natali A, Toschi E, Baldeweg S, Ciociaro D, Favilla S, Sacca L, Ferrannini E: Clustering of insulin resistance with vascular dysfunction and low-grade inflammation in type 2 diabetes. Diabetes. 2006, 55: 1133-1140. 10.2337/diabetes.55.04.06.db05-1076.CrossRefPubMed Natali A, Toschi E, Baldeweg S, Ciociaro D, Favilla S, Sacca L, Ferrannini E: Clustering of insulin resistance with vascular dysfunction and low-grade inflammation in type 2 diabetes. Diabetes. 2006, 55: 1133-1140. 10.2337/diabetes.55.04.06.db05-1076.CrossRefPubMed
9.
go back to reference de Simone G, Devereux RB, Roman MJ, Alderman MH, Laragh JH: Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults. Hypertension. 1994, 23: 600-606.CrossRefPubMed de Simone G, Devereux RB, Roman MJ, Alderman MH, Laragh JH: Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults. Hypertension. 1994, 23: 600-606.CrossRefPubMed
10.
go back to reference Cummings PM, Le BH, Lopes MB: Postmortem findings in morbidly obese individuals dying after gastric bypass procedures. Hum Pathol. 2007, 38: 593-7. 10.1016/j.humpath.2006.09.021.CrossRefPubMed Cummings PM, Le BH, Lopes MB: Postmortem findings in morbidly obese individuals dying after gastric bypass procedures. Hum Pathol. 2007, 38: 593-7. 10.1016/j.humpath.2006.09.021.CrossRefPubMed
11.
go back to reference White WB: Heart rate and the rate-pressure product as determinants of cardiovascular risk in patients with hypertension. Am J Hypertens. 1999, 12 (2 Pt 2): 50S-55S. 10.1016/S0895-7061(98)00280-5.CrossRefPubMed White WB: Heart rate and the rate-pressure product as determinants of cardiovascular risk in patients with hypertension. Am J Hypertens. 1999, 12 (2 Pt 2): 50S-55S. 10.1016/S0895-7061(98)00280-5.CrossRefPubMed
12.
go back to reference Martin JW, Briesmiester K, Bargardi A, Muzik O, Mosca L, Duvernoy CS: Weight changes and obesity predict impaired resting and endothelium-dependent myocardial blood flow in postmenopausal women. Clin Cardiol. 2005, 28: 13-18. 10.1002/clc.4960280105.CrossRefPubMed Martin JW, Briesmiester K, Bargardi A, Muzik O, Mosca L, Duvernoy CS: Weight changes and obesity predict impaired resting and endothelium-dependent myocardial blood flow in postmenopausal women. Clin Cardiol. 2005, 28: 13-18. 10.1002/clc.4960280105.CrossRefPubMed
13.
go back to reference Ikonomidis I, Mazarakis A, Papadopoulos C, Patsouras N, Kalfarentzos F, Lekakis J, Kremastinos DT, Alexopoulos D: Weight loss after bariatric surgery improves aortic elastic properties and left ventricular function in individuals with morbid obesity: a 3-year follow-up study. J Hypertens. 2007, 25: 439-447. 10.1097/HJH.0b013e3280115bfb.CrossRefPubMed Ikonomidis I, Mazarakis A, Papadopoulos C, Patsouras N, Kalfarentzos F, Lekakis J, Kremastinos DT, Alexopoulos D: Weight loss after bariatric surgery improves aortic elastic properties and left ventricular function in individuals with morbid obesity: a 3-year follow-up study. J Hypertens. 2007, 25: 439-447. 10.1097/HJH.0b013e3280115bfb.CrossRefPubMed
14.
go back to reference Pontiroli AE, Pizzocri P, Librenti MC, Vedani P, Marchi M, Cucchi E, Orena C, Paganelli M, Giacomelli M, Ferla G, Folli F: Laparoscopic adjustable gastric banding for the treatment of morbid (grade 3) obesity and its metabolic complications: a three-year study. J Clin Endocrinol Metab. 2002, 87: 3555-3561. 10.1210/jc.87.8.3555.CrossRefPubMed Pontiroli AE, Pizzocri P, Librenti MC, Vedani P, Marchi M, Cucchi E, Orena C, Paganelli M, Giacomelli M, Ferla G, Folli F: Laparoscopic adjustable gastric banding for the treatment of morbid (grade 3) obesity and its metabolic complications: a three-year study. J Clin Endocrinol Metab. 2002, 87: 3555-3561. 10.1210/jc.87.8.3555.CrossRefPubMed
15.
go back to reference Scopinaro N, Marinari GM, Camerini GB, Papadia FS, Adami GF: Specific effects of biliopancreatic diversion on the major components of metabolic syndrome. Diabetes Care. 2005, 28: 2406-2411. 10.2337/diacare.28.10.2406.CrossRefPubMed Scopinaro N, Marinari GM, Camerini GB, Papadia FS, Adami GF: Specific effects of biliopancreatic diversion on the major components of metabolic syndrome. Diabetes Care. 2005, 28: 2406-2411. 10.2337/diacare.28.10.2406.CrossRefPubMed
16.
go back to reference Pontiroli AE, Pizzocri P, Koprivec D, Vedani P, Marchi M, Arcelloni C, Paroni R, Esposito K, Giugliano D: Body weight and glucose metabolism have a different effect on circulating levels of ICAM-1, E-selectin, and endothelin-1 in humans. Eur J Endocrinol. 2004, 150: 195-200. 10.1530/eje.0.1500195.CrossRefPubMed Pontiroli AE, Pizzocri P, Koprivec D, Vedani P, Marchi M, Arcelloni C, Paroni R, Esposito K, Giugliano D: Body weight and glucose metabolism have a different effect on circulating levels of ICAM-1, E-selectin, and endothelin-1 in humans. Eur J Endocrinol. 2004, 150: 195-200. 10.1530/eje.0.1500195.CrossRefPubMed
17.
go back to reference Pontiroli AE, Pizzocri P, Saibene A, Girola A, Koprivec D, Fragasso G: Left ventricular hypertrophy and QT interval in obesity and in hypertension: effects of weight loss and of normalisation of blood pressure. Int J Obes Relat Metab Disord. 2004, 28: 1118-23. 10.1038/sj.ijo.0802733.CrossRefPubMed Pontiroli AE, Pizzocri P, Saibene A, Girola A, Koprivec D, Fragasso G: Left ventricular hypertrophy and QT interval in obesity and in hypertension: effects of weight loss and of normalisation of blood pressure. Int J Obes Relat Metab Disord. 2004, 28: 1118-23. 10.1038/sj.ijo.0802733.CrossRefPubMed
18.
go back to reference Pontiroli AE, Pizzocri P, Paroni R, Folli F: Sympathetic overactivity, endothelial dysfunction, inflammation, and metabolic abnormalities cluster in Grade III (WHO) obesity. Reversal through sustained weight loss obtained with laparoscopic adjustable gastric banding (LAGB). Diabetes Care. 2006, 29: 2735-2738. 10.2337/dc06-1417.CrossRefPubMed Pontiroli AE, Pizzocri P, Paroni R, Folli F: Sympathetic overactivity, endothelial dysfunction, inflammation, and metabolic abnormalities cluster in Grade III (WHO) obesity. Reversal through sustained weight loss obtained with laparoscopic adjustable gastric banding (LAGB). Diabetes Care. 2006, 29: 2735-2738. 10.2337/dc06-1417.CrossRefPubMed
19.
go back to reference Pontiroli AE, Folli F, Paganelli M, Micheletto G, Pizzocri P, Vedani P, Luisi F, Perego L, Morabito A, Bressani Doldi S: Laparoscopic gastric banding prevents type 2 diabetes and arterial hypertension and induces their remission in morbid obesity: a 4-year case-controlled study. Diabetes Care. 2005, 28: 2703-2709. 10.2337/diacare.28.11.2703.CrossRefPubMed Pontiroli AE, Folli F, Paganelli M, Micheletto G, Pizzocri P, Vedani P, Luisi F, Perego L, Morabito A, Bressani Doldi S: Laparoscopic gastric banding prevents type 2 diabetes and arterial hypertension and induces their remission in morbid obesity: a 4-year case-controlled study. Diabetes Care. 2005, 28: 2703-2709. 10.2337/diacare.28.11.2703.CrossRefPubMed
20.
go back to reference Long SD, O'Brien K, MacDonald KG, Leggett-Frazier N, Swanson MS, Pories WJ, Caro JF: Weight loss in severely obese subjects prevents the progression of impaired glucose tolerance to type II diabetes. A longitudinal interventional study. Diabetes Care. 1994, 17: 372-375. 10.2337/diacare.17.5.372.CrossRefPubMed Long SD, O'Brien K, MacDonald KG, Leggett-Frazier N, Swanson MS, Pories WJ, Caro JF: Weight loss in severely obese subjects prevents the progression of impaired glucose tolerance to type II diabetes. A longitudinal interventional study. Diabetes Care. 1994, 17: 372-375. 10.2337/diacare.17.5.372.CrossRefPubMed
21.
go back to reference Sjostrom L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, Dahlgren S, Larsson B, Narbro K, Sjostrom CD, Sullivan M, Wedel H, Swedish Obese Subjects Study Scientific Group: Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004, 351: 2683-2693. 10.1056/NEJMoa035622.CrossRefPubMed Sjostrom L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, Dahlgren S, Larsson B, Narbro K, Sjostrom CD, Sullivan M, Wedel H, Swedish Obese Subjects Study Scientific Group: Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004, 351: 2683-2693. 10.1056/NEJMoa035622.CrossRefPubMed
22.
go back to reference Ashrafian H, le Roux CW, Darzi A, Athanasiou T: Effects of bariatric surgery on cardiovascular function. Circulation. 2008, 118: 2091-2102. 10.1161/CIRCULATIONAHA.107.721027.CrossRefPubMed Ashrafian H, le Roux CW, Darzi A, Athanasiou T: Effects of bariatric surgery on cardiovascular function. Circulation. 2008, 118: 2091-2102. 10.1161/CIRCULATIONAHA.107.721027.CrossRefPubMed
23.
go back to reference Perego L, Pizzocri P, Corradi D, Maisano F, Paganelli M, Fiorina P, Barbieri M, Morabito A, Paolisso G, Folli F, Pontiroli AE: Circulating leptin correlates with left ventricular mass in morbid (grade III) obesity before and after weight loss induced by bariatric surgery: a potential role for leptin in mediating human left ventricular hypertrophy. J Clin Endocrinol Metab. 2005, 90: 4087-4093. 10.1210/jc.2004-1963.CrossRefPubMed Perego L, Pizzocri P, Corradi D, Maisano F, Paganelli M, Fiorina P, Barbieri M, Morabito A, Paolisso G, Folli F, Pontiroli AE: Circulating leptin correlates with left ventricular mass in morbid (grade III) obesity before and after weight loss induced by bariatric surgery: a potential role for leptin in mediating human left ventricular hypertrophy. J Clin Endocrinol Metab. 2005, 90: 4087-4093. 10.1210/jc.2004-1963.CrossRefPubMed
24.
go back to reference Iacobellis G, Ribaudo MC, Zappaterreno A, Vecci E, Tiberti C, Di Mario U, Leonetti F: Relationship of insulin sensitivity and left ventricular mass in uncomplicated obesity. Obes Res. 2003, 11: 518-524. 10.1038/oby.2003.73.CrossRefPubMed Iacobellis G, Ribaudo MC, Zappaterreno A, Vecci E, Tiberti C, Di Mario U, Leonetti F: Relationship of insulin sensitivity and left ventricular mass in uncomplicated obesity. Obes Res. 2003, 11: 518-524. 10.1038/oby.2003.73.CrossRefPubMed
25.
go back to reference Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K: Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004, 292: 1724-1737. 10.1001/jama.292.14.1724.CrossRefPubMed Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K: Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004, 292: 1724-1737. 10.1001/jama.292.14.1724.CrossRefPubMed
26.
go back to reference Kim TH, Daud A, Ude AO, DiGiorgi M, Olivero-Rivera L, Schrope B, Davis D, Inabnet WB, Bessler M: Early U.S. outcomes of laparoscopic gastric bypass versus laparoscopic adjustable silicone gastric banding for morbid obesity. Surg Endosc. 2006, 20: 202-209. 10.1007/s00464-005-0243-1.CrossRefPubMed Kim TH, Daud A, Ude AO, DiGiorgi M, Olivero-Rivera L, Schrope B, Davis D, Inabnet WB, Bessler M: Early U.S. outcomes of laparoscopic gastric bypass versus laparoscopic adjustable silicone gastric banding for morbid obesity. Surg Endosc. 2006, 20: 202-209. 10.1007/s00464-005-0243-1.CrossRefPubMed
27.
go back to reference Dolan K, Hatzifotis M, Newbury L, Fielding G: A comparison of laparoscopic adjustable gastric banding and biliopancreatic diversion in superobesity. Obes Surg. 2004, 14: 165-169. 10.1381/096089204322857500.CrossRefPubMed Dolan K, Hatzifotis M, Newbury L, Fielding G: A comparison of laparoscopic adjustable gastric banding and biliopancreatic diversion in superobesity. Obes Surg. 2004, 14: 165-169. 10.1381/096089204322857500.CrossRefPubMed
28.
go back to reference Parikh M, Ayoung-Chee P, Romanos E, Lewis N, Pachter HL, Fielding G, Ren C: Comparison of rates of resolution of diabetes mellitus after gastric banding, gastric bypass, and biliopancreatic diversion. J Am Coll Surg. 2007, 205: 631-635. 10.1016/j.jamcollsurg.2007.05.033.CrossRefPubMed Parikh M, Ayoung-Chee P, Romanos E, Lewis N, Pachter HL, Fielding G, Ren C: Comparison of rates of resolution of diabetes mellitus after gastric banding, gastric bypass, and biliopancreatic diversion. J Am Coll Surg. 2007, 205: 631-635. 10.1016/j.jamcollsurg.2007.05.033.CrossRefPubMed
29.
go back to reference NIH Consensus Development Panel: Gastrointestinal surgery for severe obesity. Ann Intern Med. 1991, 115: 956-961.CrossRef NIH Consensus Development Panel: Gastrointestinal surgery for severe obesity. Ann Intern Med. 1991, 115: 956-961.CrossRef
30.
go back to reference Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002, 287: 356-359. 10.1001/jama.287.3.356.CrossRefPubMed Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002, 287: 356-359. 10.1001/jama.287.3.356.CrossRefPubMed
31.
go back to reference Bazett HC: An analysis of time relations of the electrocardiogram. Heart. 1920, 7: 353-370. Bazett HC: An analysis of time relations of the electrocardiogram. Heart. 1920, 7: 353-370.
32.
go back to reference Zareba W, Moss AJ, Le Cessie S: Dispersion of ventricular repolarization and arrhythmic cardiac death in coronary artery disease. Am J Cardiol. 1994, 74: 550-553. 10.1016/0002-9149(94)90742-0.CrossRefPubMed Zareba W, Moss AJ, Le Cessie S: Dispersion of ventricular repolarization and arrhythmic cardiac death in coronary artery disease. Am J Cardiol. 1994, 74: 550-553. 10.1016/0002-9149(94)90742-0.CrossRefPubMed
33.
go back to reference Okin PM, Roman MJ, Devereux RB, Kligfield P: Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products. J Am Coll Cardiol. 1995, 25: 417-423. 10.1016/0735-1097(94)00371-V.CrossRefPubMed Okin PM, Roman MJ, Devereux RB, Kligfield P: Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products. J Am Coll Cardiol. 1995, 25: 417-423. 10.1016/0735-1097(94)00371-V.CrossRefPubMed
34.
go back to reference Dahlof B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, Faire U, Fyhrquist F, Ibsen H, Kristiansson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H: Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet. 2002, 359: 995-1003. 10.1016/S0140-6736(02)08089-3.CrossRefPubMed Dahlof B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, Faire U, Fyhrquist F, Ibsen H, Kristiansson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H: Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet. 2002, 359: 995-1003. 10.1016/S0140-6736(02)08089-3.CrossRefPubMed
35.
go back to reference Okin PM, Jern S, Devereux RB, Kjeldsen SE, Dahlof B, for the LIFE study group: Effect of obesity on electrocardiographic left ventricular hypertrophy in hypertensive patients. The losartan intervention for endpoint (LIFE) reduction in hypertension study. Hypertension. 2000, 35: 13-18.CrossRefPubMed Okin PM, Jern S, Devereux RB, Kjeldsen SE, Dahlof B, for the LIFE study group: Effect of obesity on electrocardiographic left ventricular hypertrophy in hypertensive patients. The losartan intervention for endpoint (LIFE) reduction in hypertension study. Hypertension. 2000, 35: 13-18.CrossRefPubMed
36.
go back to reference Rautaharju PM, Manolio TA, Siscovick D: Utility of new electrocardiographic models for left ventricular mass in older subjects. Hypertension. 1996, 28: 8-15.CrossRefPubMed Rautaharju PM, Manolio TA, Siscovick D: Utility of new electrocardiographic models for left ventricular mass in older subjects. Hypertension. 1996, 28: 8-15.CrossRefPubMed
37.
go back to reference Festa A, D'Agostino R, Rautaharju PM: Relation of systemic blood pressure, left ventricular mass, insulin sensitivity, and coronary heart disease to QT interval duration in nondiabetic and type 2 diabetic subjects. Am J Cardiol. 2000, 86: 1117-1122. 10.1016/S0002-9149(00)01170-X.CrossRefPubMed Festa A, D'Agostino R, Rautaharju PM: Relation of systemic blood pressure, left ventricular mass, insulin sensitivity, and coronary heart disease to QT interval duration in nondiabetic and type 2 diabetic subjects. Am J Cardiol. 2000, 86: 1117-1122. 10.1016/S0002-9149(00)01170-X.CrossRefPubMed
38.
go back to reference Bulatov VA, Stenehejem A, Os I: Left ventricular mass assessed by electrocardiography and albumin excretion rate as a continuum in untreated essential hypertension. J Hypertens. 2001, 19: 1473-1478. 10.1097/00004872-200108000-00016.CrossRefPubMed Bulatov VA, Stenehejem A, Os I: Left ventricular mass assessed by electrocardiography and albumin excretion rate as a continuum in untreated essential hypertension. J Hypertens. 2001, 19: 1473-1478. 10.1097/00004872-200108000-00016.CrossRefPubMed
39.
go back to reference Frige' F, Laneri M, Veronelli A, Folli F, Paganelli M, Vedani P, Marchi M, Noe' D, Ventura P, Opocher E, Pontiroli AE: Bariatric surgery in obesity: Changes of glucose and lipid metabolism correlate with changes of fat mass. Nutr Metab Cardiovasc Dis. 2009, 19: 198-204. 10.1016/j.numecd.2008.04.005.CrossRefPubMed Frige' F, Laneri M, Veronelli A, Folli F, Paganelli M, Vedani P, Marchi M, Noe' D, Ventura P, Opocher E, Pontiroli AE: Bariatric surgery in obesity: Changes of glucose and lipid metabolism correlate with changes of fat mass. Nutr Metab Cardiovasc Dis. 2009, 19: 198-204. 10.1016/j.numecd.2008.04.005.CrossRefPubMed
40.
go back to reference Valera-Mora ME, Simeoni B, Gagliardi L, Scarfone A, Nanni G, Castagneto M, Manco M, Mingrone G, Ferrannini E: Predictors of weight loss and reversal of comorbidities in malabsorptive bariatric surgery. Am J Clin Nutr. 2005, 81: 1292-1297.PubMed Valera-Mora ME, Simeoni B, Gagliardi L, Scarfone A, Nanni G, Castagneto M, Manco M, Mingrone G, Ferrannini E: Predictors of weight loss and reversal of comorbidities in malabsorptive bariatric surgery. Am J Clin Nutr. 2005, 81: 1292-1297.PubMed
41.
go back to reference Vila M, Ruiz O, Belmonte M, Riesco M, Barcelo A, Perez G, Moreiro J, Salinas R: Changes in lipid profile and insulin resistance in obese patients after Scopinaro biliopancreatic diversion. Obes Surg. 2009, 19: 299-306. 10.1007/s11695-008-9790-6.CrossRefPubMed Vila M, Ruiz O, Belmonte M, Riesco M, Barcelo A, Perez G, Moreiro J, Salinas R: Changes in lipid profile and insulin resistance in obese patients after Scopinaro biliopancreatic diversion. Obes Surg. 2009, 19: 299-306. 10.1007/s11695-008-9790-6.CrossRefPubMed
42.
go back to reference Repa JJ, Mangelsdorf DJ: Nuclear receptor regulation of cholesterol and bile acid metabolism. Curr Opin Biotechnol. 1999, 10: 557-563. 10.1016/S0958-1669(99)00031-2. ReviewCrossRefPubMed Repa JJ, Mangelsdorf DJ: Nuclear receptor regulation of cholesterol and bile acid metabolism. Curr Opin Biotechnol. 1999, 10: 557-563. 10.1016/S0958-1669(99)00031-2. ReviewCrossRefPubMed
43.
go back to reference Bays HA: Current and investigational antiobesity agents and obesity therapeutic treatment targets. Obes Res. 2004, 12: 1197-1211. 10.1038/oby.2004.151.CrossRefPubMed Bays HA: Current and investigational antiobesity agents and obesity therapeutic treatment targets. Obes Res. 2004, 12: 1197-1211. 10.1038/oby.2004.151.CrossRefPubMed
44.
go back to reference Poirier P, Hernandez TL, Weil KM, Shepard TJ, Eckel RH: Impact of Diet-Induced Weight Loss on the Cardiac Autonomic Nervous System in Severe Obesity. Obes Res. 2003, 11: 1040-1047. 10.1038/oby.2003.143.CrossRefPubMed Poirier P, Hernandez TL, Weil KM, Shepard TJ, Eckel RH: Impact of Diet-Induced Weight Loss on the Cardiac Autonomic Nervous System in Severe Obesity. Obes Res. 2003, 11: 1040-1047. 10.1038/oby.2003.143.CrossRefPubMed
45.
go back to reference Diaz A, Bourassa MG, Guertin MC, Tardif JC: Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J. 2005, 26: 967-974. 10.1093/eurheartj/ehi190.CrossRefPubMed Diaz A, Bourassa MG, Guertin MC, Tardif JC: Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J. 2005, 26: 967-974. 10.1093/eurheartj/ehi190.CrossRefPubMed
46.
go back to reference Karason K, Wikstrand J, Sjostrom L, Wendelhag I: Weight loss and progression of early atherosclerosis in the carotid artery: controlled study of obese subjects. Int J Obes. 1999, 23: 948-956. 10.1038/sj.ijo.0801024.CrossRef Karason K, Wikstrand J, Sjostrom L, Wendelhag I: Weight loss and progression of early atherosclerosis in the carotid artery: controlled study of obese subjects. Int J Obes. 1999, 23: 948-956. 10.1038/sj.ijo.0801024.CrossRef
Metadata
Title
Biliary pancreatic diversion and laparoscopic adjustable gastric banding in morbid obesity: their long-term effects on metabolic syndrome and on cardiovascular parameters
Authors
Antonio E Pontiroli
Marco Laneri
Annamaria Veronelli
Francesca Frigè
Giancarlo Micheletto
Franco Folli
Gianfranco Adami
Nicola Scopinaro
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2009
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/1475-2840-8-37

Other articles of this Issue 1/2009

Cardiovascular Diabetology 1/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.